Please login to the form below

Not currently logged in
Email:
Password:

Probuphine

This page shows the latest Probuphine news and features for those working in and with pharma, biotech and healthcare.

FDA gives green light for opioid addiction implant

FDA gives green light for opioid addiction implant

Titan and Braeburn's Probuphine is first implant of its kind to win US approval. ... It found that 63% of patients treated with the Probuphine implant had no evidence of illicit opioid use throughout the six months of treatment.

Latest news

  • FDA panel backs approval of first opioid addiction implant FDA panel backs approval of first opioid addiction implant

    In trials, Probuphine was shown to be non-inferior to daily treatment with oral buprenorphine, which is a partial opioid receptor agonist. ... At the committee meeting, Braeburn presented summary safety findings with a particular focus on the Probuphine

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...